久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese scholars publish biologics guideline in international journal

By Chen Meiling | chinadaily.com.cn | Updated: 2025-05-07 20:26
Share
Share - WeChat

A Chinese guideline on the use of biologic agents in treating chronic rhinosinusitis with nasal polyps was recently published in the 2025 China Issue of Allergy, one of the most prestigious journals in the global fields of allergology and clinical immunology.

It focuses on China-specific clinical data, systematically standardizing key aspects of biologic treatment, such as patient selection, therapeutic protocols and efficacy evaluation, providing authoritative guidance for clinical practice.

"Emerging biologics that selectively target key cytokines present a promising therapeutic alternative for patients suffering from severe, uncontrollable chronic rhinosinusitis with nasal polyps," according to the guideline.

It's the first time that Chinese scholars have published a guideline-type document in a top-tier international journal in this field, offering valuable Chinese experience for global biologic applications, said Zhang Luo, president of Beijing Tongren Hospital and guest editor of the issue, at a news conference in Beijing on Wednesday.

"In the last two decades, the problems of allergic diseases have been increasing dramatically in the world. Now we are facing 2 billion patients with allergic diseases, so this is a serious threat to humankind in the future," he said.

"In the past, we primarily relied on nasal corticosteroid sprays and oral antihistamines, both of which are chemical-based medications. These treatments have been widely used and can effectively control symptoms. However, since they require frequent administration (often daily), patients may find them inconvenient. Now, with these new biologics, just about three injections over an allergy season can effectively manage symptoms. In terms of both efficacy and duration of effect, they represent an improvement over traditional treatments," Zhang said.

He said these medicines are now available in major hospitals, such as in his hospital. However, since biologics are relatively new, their cost remains high — for example, a single injection may cost around 1,000 to 2,000 yuan ($138-276). "But as their use becomes more widespread, prices are expected to gradually decrease, making them more accessible to a larger number of patients," he added.

The 2025 China Issue of Allergy includes 32 articles focusing on the latest research progress of Chinese scholars in areas such as the link between environmental pollution and asthma pathogenesis, gut microbiota dysbiosis and allergies, as well as the mechanisms underlying drug hypersensitivity.

Cezmi Akdis, editor-in-chief of the journal Allergy, the official journal of the European Academy of Allergy and Clinical Immunology, praised China's contribution to the study of allergy, which has "immensely increased" in the last two decades.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲精品欧美精品中文字幕 | 自拍视频网 | 亚洲国产一区在线精选 | 成人在免费观看视频国产 | 午夜久久视频 | 宅男噜噜噜一区二区三区 | 在线视频 日韩 | 日韩亚洲天堂 | 亚洲精品资源网在线观看 | 久艹视频在线免费观看 | 国产原创系列在线 | 亚洲图片国产日韩欧美 | 国产欧美成人 | 久久久久在线视频 | 欧美日韩一区二区不卡三区 | 特级a毛片 | 欧美在线综合 | 国内精品2020情侣视频 | 国产成人免费片在线视频观看 | 欧美一级成人一区二区三区 | 欧美视频一区 | 欧美日韩高清观看一区二区 | 77yyxf影音先锋 | 九九99视频在线观看视频观看 | 欧美午夜免费毛片a级 | 国产三级做爰在线观看∵ | 德国女人一级毛片免费 | 狠狠五月深爱婷婷网 | 国产精品性视频免费播放 | 韩国三级日本三级香港三级黄 | 看成年女人免费午夜视频 | 92看片淫黄大片一级 | 精品欧美日韩一区二区 | 国产精品一区伦免视频播放 | 依人久久 | 亚洲一区不卡 | 欧洲欧美成人免费大片 | 免费人成在线观看视频不卡 | 精品成人一区二区三区免费视频 | 久久综合色播 | 国模偷拍在线观看免费视频 |